MedTrace Logo

Feasibility and Acceptability of Switching to E-cigarettes Among Cigarette Smokers Engaged in SUD Treatment

NCT05918887 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2025-05-13

No results posted yet for this study

Summary

The purpose of the proposed study is to examine the feasibility of integrating a smoking harm reduction program featuring provision of e-cigarettes and tailored instructions to switch into an existing substance use disorder treatment program. This longitudinal study includes three weeks of micro-surveys delivered via text messages to evaluate the intervention's feasibility and acceptability, gather initial effectiveness data, and understand participants' lived experience of smoking and vaping while engaged in substance use disorder treatment.

Conditions

  • Tobacco Dependence Caused by Cigarettes

Interventions

DEVICE

NJOY ACE commercial e-cigarette

The NJOY ACE is the commercial version of the Standardized Research E-Cigarette (SREC), which was developed by NIDA with NJOY for research purposes. Nicotine pods: * Sealed, pre-filled, non-refillable * 1.9 mL e-liquid with 5% w/w nicotine * Approx 300 (280-330) puffs/pod Nicotine liquid characteristics: * Volume of liquid per pod 1.9 mL * Active (nicotine USP 5% wt/wt) * Propylene Glycol USP \& Vegetable Glycerin USP - PG/VG Ratio 0.77 * Lactic Acid USP Battery characteristics: * USB Rechargeable * Storage Capacity \~ 400 mAh * Approx 200 (3s) puffs / charge * 300 charge cycles to \> 80% initial capacity * Time to full charge 75 - 85 min * Voltage / Temperature settings not user adjustable

Sponsors & Collaborators

  • University of Nevada, Reno

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-18
Primary Completion
2024-09-13
Completion
2024-09-13
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05918887 on ClinicalTrials.gov